PHAM QUANG X (CEO and Chairman) sold 4.6% of their position (8.29K shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $36.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/5/2026ACC: 0001213900-26-065925
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
-8.29K
Net shares
Net seller
$36.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
8.29K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.32K
Price / share
$4.26
Trade value
$9.90K
% of position
1.3%
6/3/2026
181.51K→179.19K
Common Stock
Direct
Shares
−3.90K
Price / share
$4.41
Trade value
$17.19K
% of position
2.2%
6/4/2026
179.19K→175.29K
Common Stock
Direct
Shares
−2.06K
Price / share
$4.42
Trade value
$9.12K
% of position
1.2%
6/5/2026
175.29K→173.22K
Total
Net shares
−8.29K
Net value
-$36.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | S · Sale | −2.32K | $4.26 | $9.90K | 1.3% | 181.51K | 179.19K |
| Common Stock Direct | 6/4/2026 | S · Sale | −3.90K | $4.41 | $17.19K | 2.2% | 179.19K | 175.29K |
| Common Stock Direct | 6/5/2026 | S · Sale | −2.06K | $4.42 | $9.12K | 1.2% | 175.29K | 173.22K |
| Total | −8.29K | -$36.21K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned200K
Total
200K indirect200K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200K | Indirect |
| Total | 200K | 200K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported